Stem Cell Research

Research studies confirm promise of novel cord blood stem cell from biomedical company

Published in Biotech Business Week, January 9th, 2006

BioE, Inc. announced that studies conducted by researchers at the University of Newcastle upon Tyne in the United Kingdom and the University of Minnesota in Minneapolis confirm the promise of the company's novel cord blood stem cell - the multilineage progenitor cell (MLPC) - for tissue engineering, bone marrow transplantation and regenerative medicine applications.

Researchers at the University of Newcastle upon Tyne found BioE's MLPC to be homogeneous and extremely immature in a comparative study, thus offering "exciting capabilities for tissue engineering applications." Results of this study were presented at The American Society of Cellular Biology's 45th Annual...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2006-01-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry